View Single Post
Old 06-01-2003, 08:48 PM   #1
Lolly
Guest
 
Posts: n/a
In Phase III trials patients with metastatic breast cancer who received WBR plus RSR13 achieved longer survival. RSR13 works by sensitizing oxygen-deprived tumor tissues to enhance the effectiveness of standard radiation therapy and chemotherapy.
  Reply With Quote